Developing blood tests for early detection of cancer
We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster.
Visit website: https://guardanthealth.com/
Guardant Health News
Liquid biopsy detects early signs of cancer
Smithsonian - 07-Feb-2020
Analyzing cancer DNA in blood can present easier diagnosis and more effective treatmentsRead more...